14
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Effects of itraconazole and terbinafine on Leishmania major lesions in BALB/c mice

&
Pages 787-791 | Received 12 Nov 1999, Accepted 20 Sep 2000, Published online: 15 Nov 2016

REFERENCES

  • Ahonen, J., Olkkola, K. T. & Neuvonen, P. J. (1995). Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers. British Journal of Clinical Pharmacology, 40, 270–272.
  • Al-Fouzan, A. S., Al-Saleh, Q. A., Najem, N. M. & Rostom, A. I. (1991). Cutaneous leishmaniasis in Kuwait. Clinical experiance with itraconazole. International Journal of Dermatology, 30, 519–521.
  • Bahamdan, K. A., Tallab, T. M., Johargi, H., Nourad, M. M., Ibrahim, K., El Sherbini, A. H., Karkashan, E., Khare, A. K. & Nauri, M. M. (1997). Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study. International Journal of Dermatology, 36, 59–60.
  • Balzan, M. & Fenech, F. (1992). Acute renal failure in visceral leishmaniasis treated with sodium stibogluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 515–516.
  • Beach, D. H., Goad, L. J. & Holz, G. G. (1988). Effects on antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes. Molecular and Biochemical Parasitology, 31, 149–162.
  • Berman, J. D., Ksionski, G., Chapman, W. L., Waits, V. B. & Hanson, W. L. (1992). Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrobial Agents and Chemotherapy, 36, 1978–1980.
  • Chance, M. L. (1995). New developments in the chemotherapy of leishmaniasis. Annals of Tropical Medicine and Parasitology, 89 (Suppl. 1), 37–43.
  • Dietze, R., Fagundes, S. M. S., Brito, E. F., Milan, E. P., Feitosa, T. F., Suassuna, A. B., Fonschif-frey, G., Ksionski, G. & Dember, J. (1995). Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 309–311.
  • Dogra, J. & Saxena, V. N. (1996). Itraconazole and leishmaniasis: a randomized double-blind trial in cutaneous disease. International Journal for Parasitology, 26, 1413–1415.
  • Dogra, J., Aneja, N., Lal, B. B. & Mishra, S. N. (1990). Cutaneous leishmaniasis in India. Clinical experience with itraconazole. International Journal of Dermatology, 29, 661–662.
  • Enden, V., Gompel, V. A., Stevens, A., Vandeghinste, N., Ray, D., Gigase, P., Beule, K. & Enden, V. J. (1994). Treatment of cutaneous leishmaniasis with oral itraconazole. International Journal of Dermatology, 33, 285–286.
  • Gebre-Hiwot, A. & Frommel, D. (1993). The in-vitro anti-leishmanial activity of inhibitors of ergosterol biosynthesis. Journal of Antimicrobial Chemotherapy, 32, 837–842.
  • Giacchino, R., Giambartolomei, G., Tasso, L., Timitilli, A., Castagnola, E., Brisigotti, M. & Micalizzi, C. (1993). Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 310.
  • Haughan, P. A., Chance, M. L. & Goad, L. J. (1992). Synergism in vitro of lovastatin and miconazole as anti-leishmanial agents. Biochemical Pharmacology, 44, 2199–2206.
  • Haughan, P. A., Chance, M. L. & Goad, L. J. (1993). Effects of sinfungin on growth and sterol composition of Leishmania promastigotes. Experimental Parasitology, 77, 147–154.
  • Iwu, M. M., Jackson, J. E. & Schuster, B. G. (1994). Medicinal plants in the fight against leishmaniasis. Parasitology Today, 10, 65–68.
  • Larbi, E. B., Al-Khawajah, A., Al-Gindan, Y., Jain, S., Abahusain, A. & Al-Zayer, A. (1995). A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia. American Journal of Tropical Medicine and Hygiene, 52, 166–168.
  • Maldonado, R. A., Molina, J., Payares, G. & Urbina, J. A. (1993). Experimental chemotherapy with combination of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrobial Agents and Chemotherapy, 37, 1353–1359.
  • Negre, E., Chance, M. L., Hanboula, S. Y., Monsigny, M., Roche, A. C., Mayer, R. M. & Hommel, M. (1992). Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins. Antimicrobial Agents and Chemotherapy, 36, 2228–2232.
  • New, R. R. C., Chance, M. L. & Heath, S. (1981). Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. Journal of Antimicrobial Chemotherapy, 8, 371–381.
  • Rangel, H., Dagger, F., Hernandez, A., Liendo, A. & Urbina, J. (1996). Naturally azole-resistant Leishmanai braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes. Antimicrobial Agents and Chemotherapy, 40, 2785–2791.
  • Urbina, J. A. (1997). Lipid biosynthesis pathways as chemotheraputic targets in kinetoplastid parasites. Parasitology, 114 (Suppl.), 91–99.
  • Vannier-Santos, M. A., Urbina, J. A., Martiny, A., Neves, A. & Souza, W. (1995). Alteration induced by the antifungal compounds ketoconazole and terbinafine in Leishmania. Journal of Eukaryotic Microbiology, 42, 337–346. World Health Organization (1990). Control of Leishmaniasis. Report of the WHO Expert Committee. Technical Report Series No. 793. Geneva: WHO.
  • Zakai, H. A., Chance, M. L. & Bates, P. A. (1998). In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana. Parasitology, 116, 305–309.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.